Possibia

1439126

Last Update Posted: 2014-10-27

Recruiting has ended

All Genders

accepted

6 Years-17 Years

135 Estimated Participants

No Expanded Access

Interventional Study

Does not accept healthy volunteers

Efficacy & Safety of KAPVAY™ Extended-Release in Children & Adolescents With Attention Deficit Hyperactivity Disorder

The purpose of this study is to determine the long-term efficacy and safety of KAPVAY™ (clonidine hydrochloride) extended-release in children and adolescents with Attention Deficit Hyperactivity Disorder (ADHD)

Eligibility

Relevant conditions:

Attention Deficit Hyperactivity Disorder

If you aren't sure if you meet the criteria above speak to your healthcare professional. Criteria may be updated but not reflected here, do not hesitate to contact the trial if you think are close to fitting criteria.

locations

Data sourced from ClinicalTrials.gov